A closer look at the bad deal trial: Beyond clinical equipoise

Lynn A. Jansen

doi:10.2307/3528331

A closer look at the bad deal trial: Beyond clinical equipoise

Lynn A. Jansen

Research output: Contribution to journal › Review article › peer-review

28 Scopus citations

Abstract

Some commentators have recently proposed that "clinical equipoise," although widely accepted, is not necessary for morally acceptable research on human subjects. If this concept is rejected, however, we may find that trials not in the best medical interests of their subjects-"bad deal trials"-could be justified. To avoid exploiting participants, we must find a way to distribute the risks fairly, even if it means embracing radical changes in the way clinical research is conducted.

Original language	English (US)
Pages (from-to)	29-36
Number of pages	8
Journal	Hastings Center Report
Volume	35
Issue number	5
DOIs	https://doi.org/10.2307/3528331
State	Published - 2005
Externally published	Yes

ASJC Scopus subject areas

Health(social science)
Issues, ethics and legal aspects
Philosophy
Health Policy

Access to Document

10.2307/3528331

Cite this

@article{9fd2fedb6c3141c6b840edbd08c96e5f,

title = "A closer look at the bad deal trial: Beyond clinical equipoise",

abstract = "Some commentators have recently proposed that {"}clinical equipoise,{"} although widely accepted, is not necessary for morally acceptable research on human subjects. If this concept is rejected, however, we may find that trials not in the best medical interests of their subjects-{"}bad deal trials{"}-could be justified. To avoid exploiting participants, we must find a way to distribute the risks fairly, even if it means embracing radical changes in the way clinical research is conducted.",

author = "Jansen, {Lynn A.}",

year = "2005",

doi = "10.2307/3528331",

language = "English (US)",

volume = "35",

pages = "29--36",

journal = "Hastings Center Report",

issn = "0093-0334",

publisher = "Hastings Center",

number = "5",

}

TY - JOUR

T1 - A closer look at the bad deal trial

T2 - Beyond clinical equipoise

AU - Jansen, Lynn A.

PY - 2005

Y1 - 2005

N2 - Some commentators have recently proposed that "clinical equipoise," although widely accepted, is not necessary for morally acceptable research on human subjects. If this concept is rejected, however, we may find that trials not in the best medical interests of their subjects-"bad deal trials"-could be justified. To avoid exploiting participants, we must find a way to distribute the risks fairly, even if it means embracing radical changes in the way clinical research is conducted.

AB - Some commentators have recently proposed that "clinical equipoise," although widely accepted, is not necessary for morally acceptable research on human subjects. If this concept is rejected, however, we may find that trials not in the best medical interests of their subjects-"bad deal trials"-could be justified. To avoid exploiting participants, we must find a way to distribute the risks fairly, even if it means embracing radical changes in the way clinical research is conducted.

UR - http://www.scopus.com/inward/record.url?scp=31544473150&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=31544473150&partnerID=8YFLogxK

U2 - 10.2307/3528331

DO - 10.2307/3528331

M3 - Review article

C2 - 16295262

AN - SCOPUS:31544473150

SN - 0093-0334

VL - 35

SP - 29

EP - 36

JO - Hastings Center Report

JF - Hastings Center Report

IS - 5

ER -

A closer look at the bad deal trial: Beyond clinical equipoise

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this